Total medical devices industry deals in Q4 2018 worth $13.23bn were announced, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked a decrease of 2.1% over the previous quarter and a rise of 6% when compared with the last four-quarter average of $12.48bn.
In terms of number of deals, the sector saw a drop of 20.52% over the last four-quarter average with 275 deals against the average of 346 deals.
In value terms, North America led the activity with deals worth $6.98bn.
The top five medical devices deals accounted for 71.16% of the overall value in the sector globally during Q4 2018.
The combined value of the top five medical devices deals stood at $9.42bn, against the overall value of $13.23bn recorded for the quarter.
Medical devices industry deals in Q4 2018: Top deals
The top announced medical devices deal tracked by GlobalData in Q4 2018 was Bravo Bidco’s $4.24bn acquisition of BTG.
In second place was Colfax’s acquisition of DJO Global for $3.15bn and in third place was Astorg Partners’ $1.16bn private equity deal with Nemera La Verpilliere.
Gurnet Point Capital’s $504m private equity deal with Corium International and ConMed Corp’s acquisition of Buffalo Filter LLC for $365m held fourth and fifth positions, respectively.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
Verdict’s parent company GlobalData plc provides business information to 4,000 of the world’s largest companies.